BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25736761)

  • 1. Methodology to study NF-κB/RelA ubiquitination in vivo.
    Li H; Starokadomskyy P; Burstein E
    Methods Mol Biol; 2015; 1280():371-81. PubMed ID: 25736761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of NF-κB subunits by ubiquitination.
    Collins PE; Colleran A; Carmody RJ
    Methods Mol Biol; 2015; 1280():355-70. PubMed ID: 25736760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
    Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J
    Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
    Hochrainer K; Pejanovic N; Olaseun VA; Zhang S; Iadecola C; Anrather J
    Nucleic Acids Res; 2015 Nov; 43(20):9889-904. PubMed ID: 26476452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
    Schweitzer K; Pralow A; Naumann M
    J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IκB degradation dynamics and IκB-α ubiquitination.
    Starokadomskyy P; Burstein E
    Methods Mol Biol; 2015; 1280():15-24. PubMed ID: 25736741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
    Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
    Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.
    Hochrainer K; Racchumi G; Zhang S; Iadecola C; Anrather J
    Cell Mol Life Sci; 2012 Jun; 69(12):2057-73. PubMed ID: 22261743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
    Maine GN; Mao X; Komarck CM; Burstein E
    EMBO J; 2007 Jan; 26(2):436-47. PubMed ID: 17183367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability.
    Park M; Yong Y; Choi SW; Kim JH; Lee JE; Kim DW
    Nat Cell Biol; 2007 Mar; 9(3):287-98. PubMed ID: 17310243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
    Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
    Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
    Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
    Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB signaling pathway is inhibited by heat shock independently of active transcription factor HSF1 and increased levels of inducible heat shock proteins.
    Janus P; Pakuła-Cis M; Kalinowska-Herok M; Kashchak N; Szołtysek K; Pigłowski W; Widlak W; Kimmel M; Widlak P
    Genes Cells; 2011 Dec; 16(12):1168-75. PubMed ID: 22077664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy.
    Rajakumar D; Senguttuvan S; Alexander M; Oommen A
    Life Sci; 2014 Jul; 108(1):54-61. PubMed ID: 24846833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach.
    Lee J; Choi K; Choi C
    Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination.
    Thoms HC; Loveridge CJ; Simpson J; Clipson A; Reinhardt K; Dunlop MG; Stark LA
    Cancer Res; 2010 Jan; 70(1):139-49. PubMed ID: 20048074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
    Chen Y; Li HH; Fu J; Wang XF; Ren YB; Dong LW; Tang SH; Liu SQ; Wu MC; Wang HY
    Cell Res; 2007 Dec; 17(12):1020-9. PubMed ID: 18040287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to detect NF-κB acetylation and methylation.
    Chen J; Chen LF
    Methods Mol Biol; 2015; 1280():395-409. PubMed ID: 25736763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.